You are here: Industry Insights > acquisition

News List

Bormioli Pharma to Acquire GCL Pharma for €8.9M contractpharma
March 19, 2020
Expands industrial footprint by adding new technologies to extend its oral and parenteral product range.
Bora Pharmaceuticals to Acquire GSK Mississauga-based Facility contractpharma
March 10, 2020
Bora Pharmaceuticals and GSK have entered into an agreement under which Bora will acquire GSK’s Mississauga, Ontario (Canada) facility.
Bactiguard Completes Acquisition of Vigilenz prnasia
March 03, 2020
Bactiguard Holding AB (publ) ("Bactiguard") has completed the acquisition of Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz), which was announced on 4 February 2020.
Merck closes $2.7bn acquisition of biopharmaceutical firm ArQule pharmaceutical-technology
January 19, 2020
Merck (MSD) has completed its previously announced acquisition of US-based biopharmaceutical company ArQule. The $2.7bn deal closed following completion of the cash tender offer that involved acquiring ArQule’s outstanding shares of common stock at $20 pe
WuXi Biologics to acquire drug manufacturing plant in Germany pharmaceutical-technology
January 19, 2020
WuXi Biologics has signed an acquisition agreement to take over a Bayer’s drug product manufacturing plant in Leverkusen, Germany. The Leverkusen plant will be the Chinese firm’s first drug product facility in Europe bolstering its commercial manufacturin
WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany(1) PharmaSources/Wuxi Biologics
January 16, 2020
WuXi Biologics will be the back-up manufacturer for Kovaltry™ of Bayer
Astellas Completes Acquisition of Audentes Therapeutics americanpharmaceuticalreview
January 16, 2020
Astellas Pharma has successfully completed the previously announced acquisition of Audentes Therapeutics, through a tender offer by its indirect wholly-owned subsidiary Asilomar Acquisition for all of the issued and outstanding shares of common stock of .
Lilly to acquire Dermira for approximately $1.1bn pharmaceutical-technology
January 14, 2020
Eli Lilly and Company (Lilly) has signed a definitive agreement to acquire biopharmaceutical firm Dermira for approximately $1.1bn in cash. As agreed, Lilly will acquire all outstanding shares of Dermira for $18.75 per share.
VolitionRx Completes Acquisition of Octamer GmbH prnasia
January 11, 2020
Volition also announced the receipt of additional non-dilutive funding in the form of a $550,000 (Euro 500,000) unsecured loan from Namur Invest to assist with the Octamer acquisition.
Charles River Laboratories wraps up $380m acquisition of HemaCare pharmaceutical-business-review
January 09, 2020
Charles River Laboratories International has wrapped up its $380m acquisition of HemaCare, a California-based human-derived cellular products provider for the cell therapy market.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page